Haydee Olinger
Known title: DirectorCIK: 0001749345
Haydee Olinger's purchase track record
Haydee Olinger has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/31/2024 | STKS | $30K | -26.0% | -32.1% | +14.3% |
| 12/15/2022 | STKS | $25K | +31.4% | +20.0% | +13.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| STKS | ▲ Buy | Grant | 19,531 | $0 | 9/30/2026 | View on chart |
| STKS | ▲ Buy | Grant | 15,547 | $0 | 6/30/2026 | View on chart |
| STKS | ▲ Buy | Grant | 17,556 | $0 | 3/31/2026 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,250 | — | 3/2/2026 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,600 | — | 3/1/2026 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,675 | — | 2/28/2026 | View on chart |
| TACT | ▲ Buy | Option Exercise | 2,850 | — | 2/27/2026 | View on chart |
| STKS | ▲ Buy | Grant | 17,857 | $0 | 12/31/2025 | View on chart |
| STKS | ▲ Buy | Grant | 10,557 | $0 | 9/30/2025 | View on chart |
| STKS | ▲ Buy | Grant | 6,481 | $0 | 6/30/2025 | View on chart |
| STKS | ▲ Buy | Grant | 8,779 | $0 | 3/31/2025 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,100 | $0 | 3/4/2025 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,250 | $0 | 3/2/2025 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,600 | $0 | 3/1/2025 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,675 | $0 | 2/28/2025 | View on chart |
| STKS | ▲ Buy | Grant | 9,051 | $0 | 12/31/2024 | View on chart |
| STKS | ▲ Buy | Grant | 7,133 | $26K | 9/30/2024 | View on chart |
| STKS | ▲ Buy | Grant | 6,176 | $26K | 6/28/2024 | View on chart |
| STKS | ▲ Buy | Open Market | 5,740 | $30K | 5/31/2024 | View on chart |
| STKS | ▲ Buy | Grant | 4,581 | $26K | 4/2/2024 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,100 | $0 | 3/4/2024 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,250 | $0 | 3/2/2024 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,600 | $0 | 3/1/2024 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,150 | $0 | 2/27/2024 | View on chart |
| STKS | ▲ Buy | Grant | 4,289 | $26K | 12/29/2023 | View on chart |
| STKS | ▲ Buy | Grant | 4,773 | $26K | 9/29/2023 | View on chart |
| STKS | ▲ Buy | Grant | 3,586 | $26K | 6/30/2023 | View on chart |
| STKS | ▲ Buy | Grant | 3,241 | $26K | 3/31/2023 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,100 | $0 | 3/4/2023 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,250 | $0 | 3/2/2023 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,200 | $0 | 2/27/2023 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,150 | $0 | 2/27/2023 | View on chart |
| STKS | ▲ Buy | Grant | 2,232 | $14K | 12/30/2022 | View on chart |
| STKS | ▲ Buy | Open Market | 4,000 | $25K | 12/15/2022 | View on chart |
| STKS | ▲ Buy | Grant | 2,117 | $14K | 9/30/2022 | View on chart |
| TACT | ▲ Buy | Option Exercise | 500 | — | 8/9/2022 | View on chart |
| STKS | ▲ Buy | Grant | 1,915 | $14K | 6/29/2022 | View on chart |
| STKS | ▲ Buy | Grant | 1,343 | $14K | 3/30/2022 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,100 | $0 | 3/4/2022 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,200 | $0 | 2/27/2022 | View on chart |
| TACT | ▲ Buy | Option Exercise | 1,150 | $0 | 2/27/2022 | View on chart |
| STKS | ▲ Buy | Grant | 845 | $10K | 12/29/2021 | View on chart |
| STKS | ▲ Buy | Grant | 1,169 | $0 | 9/30/2021 | View on chart |
| STKS | ▲ Buy | Grant | 4,854 | $0 | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
TransAct Announces EPIC TT+ Launch to Expand Gaming Tech
TransAct has announced the launch of its EPIC TT+ platform, a new gaming technology that extends beyond traditional slot machines. The move is intended to broaden the company's product portfolio and tap into newer gaming markets. The news arrives while the share price sits near its 52‑week low and the RSI is below 40, indicating a potential for further downside pressure.
TransAct Announces EPIC TT+ Launch to Expand Gaming Tech. TransAct has announced the launch of its EPIC TT+ platform, a new gaming technology that extends beyond traditional slot machines. The move is intended to broaden the company's product portfolio and tap into newer gaming markets. The news arrives while the share price sits near its 52‑week low and the RSI is below 40, indicating a potential for further downside pressure.